VIB-RUG Department of Molecular Biomedical Research

Molecular ImmunoBiotechnology Unit

 

 

 

 

 

 

 

 

Bispecific Antibodies: 

new models for better therapy

Here are some points that are elaborated further in this site. They will help you to get an idea on the clinical use of antibodies, of bispecific antibodies, and of recombinant models to make bispecific antibodies.

bullet

Antibodies are attractive tools to develop therapeutics
bullet

Overview of moAbs on the market

bullet

Immunotherapy might induce long-term protection.
bullet

Immunology and danger

bullet

Tumor antigens

bullet

Immunotherapy

bullet

Immunotherapy with bispecific antibodies 

bullet

Clinical results with bispecific antibodies.

bullet

How to make bispecific antibodies?

bullet

Controlled heterodimerization of trispecific antibodies: the Tribody manifold

bullet

Antibody links

bullet

Therapeutic Antibody Companies

 
Home

Contact

Research projects

Publications

After eight

Check out 

links to:

MABs on the market
Antibody Companies
Immune Therapy Companies
Custom protein expression and purification
Biotech in Flanders
Flanders Universities
Flanders Biotech Policy

                  

2002 Webmaster